Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGL | P06737 | 16/20 | 0.52 |
| ▸ | PYGM | P11217 | 16/20 | 0.52 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | GLA | P06280 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | CASP1 | P29466 | 1/20 | 0.48 |
| ▸ | CASP7 | P55210 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7945527 | 0.88 | LMNA (0.47) | PYGLPYGMGAATSHRKDM4E | |
| SCHEMBL11681868 | 0.84 | PYGL (0.49) | PYGLPYGMGAATSHRKDM4E | |
| SCHEMBL14987090 | 0.83 | TSHR (0.74) | PYGLPYGMGAATSHRKDM4E | |
| SCHEMBL11691222 | 0.80 | PYGL (0.56) | PYGLPYGMGAATSHRKDM4E | |
| SCHEMBL3034308 | 0.79 | ALDH1A1 (0.49) | PYGLPYGMGAATSHRKDM4E | |
| SCHEMBL29259269 | 0.78 | GAA (0.48) | PYGLPYGMGAATSHRKDM4E | |
| SCHEMBL4881545 | 0.78 | LMNA (0.61) | PYGLPYGMGAATSHRKDM4E | |
| SCHEMBL16178523 | 0.78 | KDM4E (0.66) | PYGLPYGMGAATSHRKDM4E | |
| SCHEMBL11008635 | 0.77 | KDM4E (0.54) | PYGLPYGMGAATSHRKDM4E | |
| SCHEMBL16178021 | 0.77 | TSHR (0.47) | GAATSHRKDM4EALDH1A1GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10258498-B2 | 1,4-dihydropyridine derivatives with Hsp modulating activity | RICHTER GEDEON NYRT. (HU) | 2019-04-16 | — | — | US | claimed |
| US-20140315893-A1 | 1,4- DIHYDROPYRIDINE DERIVATIVES WITH HSP MODULATING ACTIVITY | RICHTER GEDEON NYRT. (HU) | 2014-10-23 | — | — | US | claimed |
| US-10660789-B2 | 1,4-dihydropyridine derivatives with HSP modulating activity | RICHTER GEDEON NYRT. (HU) | 2020-05-26 | — | — | US | disclosed |
| EP-2782573-B1 | 1,4-DIHYDROPYRIDINE DERIVATIVES WITH HSP MODULATING ACTIVITY | RICHTER GEDEON NYRT (HU) | 2019-10-09 | — | — | EP | disclosed |
| US-20190192336-A1 | 1,4-Dihydropyridine Derivatives With HSP Modulating Activity | LIPIDART KUTATÓ FEJLESZTO ÉS TANÁCSADÓ KFT. (HU) | 2019-06-27 | — | — | US | disclosed |
| US-10258498-B2 | 1,4-dihydropyridine derivatives with Hsp modulating activity | RICHTER GEDEON NYRT. (HU) | 2019-04-16 | — | — | US | disclosed |
| US-20140315893-A1 | 1,4- DIHYDROPYRIDINE DERIVATIVES WITH HSP MODULATING ACTIVITY | RICHTER GEDEON NYRT. (HU) | 2014-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140315893-A1 | 1,4- DIHYDROPYRIDINE DERIVATIVES WITH HSP MODULATING ACTIVITY | HSF1, HSPB1, HSP90AB1 | PYGL 2062/4885PYGM 4296/4885GAA 2724/4885 |
| US-10258498-B2 | 1,4-dihydropyridine derivatives with Hsp modulating activity | HSF1, HSPB1, HSP90AB1 | PYGL 2062/4885PYGM 4296/4885GAA 2724/4885 |
| US-10660789-B2 | 1,4-dihydropyridine derivatives with HSP modulating activity | HSF1, HSPB1, HSP90AB1 | PYGL 2062/4885PYGM 4296/4885GAA 2724/4885 |
| US-20190192336-A1 | 1,4-Dihydropyridine Derivatives With HSP Modulating Activity | HSF1, HSPB1, HSP90AB1 | PYGL 2062/4885PYGM 4296/4885GAA 2724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.